“Induced Antileukemic Activity After Blast Modulation Is Independent from Immune Checkpoint Marker Expression on Patients’ Blasts or T Cells”. 2025. Archives of Clinical and Biomedical Research 9 (6): 521-41. https://fortunejournals.org/ojs/index.php/acbr/article/view/15154.